Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis - PubMed (original) (raw)
Review
Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis
R Kalluri. Cold Spring Harb Symp Quant Biol. 2002.
No abstract available
Similar articles
- New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.
Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP Jr, Hudson BG, Brooks PC. Petitclerc E, et al. J Biol Chem. 2000 Mar 17;275(11):8051-61. doi: 10.1074/jbc.275.11.8051. J Biol Chem. 2000. PMID: 10713126 - A reevaluation of integrins as regulators of angiogenesis.
Hynes RO. Hynes RO. Nat Med. 2002 Sep;8(9):918-21. doi: 10.1038/nm0902-918. Nat Med. 2002. PMID: 12205444 Review. - Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y, Colorado PC, Kalluri R. Maeshima Y, et al. J Biol Chem. 2000 Aug 4;275(31):23745-50. doi: 10.1074/jbc.C000186200. J Biol Chem. 2000. PMID: 10837460 - Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M, Kalluri R. Eikesdal HP, et al. Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15040-5. doi: 10.1073/pnas.0807055105. Epub 2008 Sep 25. Proc Natl Acad Sci U S A. 2008. PMID: 18818312 Free PMC article. - Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
Sudhakar A, Boosani CS. Sudhakar A, et al. Pharm Res. 2008 Dec;25(12):2731-9. doi: 10.1007/s11095-008-9634-z. Epub 2008 Jun 13. Pharm Res. 2008. PMID: 18551250 Free PMC article. Retracted. Review.
Cited by
- Basement membrane and stroke.
Yao Y. Yao Y. J Cereb Blood Flow Metab. 2019 Jan;39(1):3-19. doi: 10.1177/0271678X18801467. Epub 2018 Sep 18. J Cereb Blood Flow Metab. 2019. PMID: 30226080 Free PMC article. - Extracellular Matrix, a Hard Player in Angiogenesis.
Mongiat M, Andreuzzi E, Tarticchio G, Paulitti A. Mongiat M, et al. Int J Mol Sci. 2016 Nov 1;17(11):1822. doi: 10.3390/ijms17111822. Int J Mol Sci. 2016. PMID: 27809279 Free PMC article. Review. - Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.
Gunda V, Verma RK, Sudhakar YA. Gunda V, et al. Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):7828-35. doi: 10.1167/iovs.12-10870. Invest Ophthalmol Vis Sci. 2013. PMID: 24194191 Free PMC article. - L-arginine mediated renaturation enhances yield of human, α6 Type IV collagen non-collagenous domain from bacterial inclusion bodies.
Gunda V, Boosani CS, Verma RK, Guda C, Sudhakar YA. Gunda V, et al. Protein Pept Lett. 2012 Oct;19(10):1112-21. doi: 10.2174/092986612802762750. Protein Pept Lett. 2012. PMID: 22512648 Free PMC article. - Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.
Albini A, Indraccolo S, Noonan DM, Pfeffer U. Albini A, et al. Clin Exp Metastasis. 2010 Aug;27(6):419-39. doi: 10.1007/s10585-010-9312-5. Epub 2010 Apr 10. Clin Exp Metastasis. 2010. PMID: 20383568 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources